Our results have consolidated the role of KIF5B-RET fusion gene in the pathogenesis of NSCLC and identified STAT3 as a key mediator of the transforming activity of KIF5B-RET positive lung cancer cells. The gene discussed is KIF5B; the disease is lung carcinoma.